ERBB2 and breast cancer: Nevertheless, HER2-positive breast cancers are usually good responders to neoadjuvant treatment and most of them disappear, although breast microcalcifications do not always do so, nor is an omission of axilla clearance accepted when the initial involvement was extensive.